To ask the Secretary of State for Health and Social Care, whether he has considered including lipedema as a relevant condition for NHS prescription of (a) Mounjaro injections and (b) other weight loss treatments.
Semaglutide, brand name Wegovy, tirzepatide, brand name Mounjaro, and liraglutide, brand name Saxenda, are approved for the management of obesity. They are recommended as cost-effective for use on the National Health Service for people who have a body mas...
Obesity: Drugs